The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties

Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692 · see citing works

Functional diversity of helper T lymphocytes

Abbas, A. K., MURPHY, K. M. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,383 · see citing works

Lymphocyte responses and cytokines

Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,832 · see citing works

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,648 · see citing works

Lymphokine Production by Human T Cells in Disease States

Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001303 · Cited by 1,332 · see citing works

Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).

Ferber, I., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. (1996) · Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 1,088 · see citing works

Regulation of Immunity to Parasites by T Cells and T Cell-Derived Cytokines

Sher, A., & Coffman, R. L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002125 · Cited by 841 · see citing works

Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological tolerance

Fueyo, A. S., Tian, J. Y., Picarella, D., Domenig, C. M., Zheng, X. X., Sabatos, C. A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V. K., et al. (2003) · Nature Immunology · doi:10.1038/ni987 · Cited by 713 · see citing works

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance

Sabatos, C. A., Chakravarti, S., Cha, E., Schubart, A., Fueyo, A. S., Zheng, X. X., Coyle, A. J., Strom, T. B., Freeman, G. J., & Kuchroo, V. K. (2003) · Nature Immunology · doi:10.1038/ni988 · Cited by 629 · see citing works

Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes.

Lam, M., Dubyak, G., Chen, L., Núñez, G., Miesfeld, R. L., & Distelhorst, C. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6569 · Cited by 602 · see citing works

Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways

Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W., & Vandenabeele, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.919 · Cited by 556 · see citing works

Functional diversity of T lymphocytes due to secretion of different cytokine patterns

Street, N. E., & Mosmann, T. R. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.2.1825981 · Cited by 530 · see citing works

Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

Rabinovich, G. A., Baum, L. G., Tinari, N., Paganelli, R., Natoli, C., Liu, F., & Iacobelli, S. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02232-9 · Cited by 527 · see citing works

Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family

McIntire, J. J., Umetsu, S. E., Akbari, O., Potter, M., Kuchroo, V. K., Barsh, G. S., Freeman, G. J., Umetsu, D. T., & DeKruyff, R. H. (2001) · Nature Immunology · doi:10.1038/ni739 · Cited by 501 · see citing works

Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis

Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., Azuma, M., Yagita∥, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 501 · see citing works

Tolerance and Autoimmunity

Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 462 · see citing works

Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

Weiner, H. L. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01456-3 · Cited by 390 · see citing works

Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis

Rabinovich, G. A., Daly, G. R., Dreja, H. S., Tailor, H., Riera, C. M., Hirabayashi, J., & Chernajovsky, Y. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.385 · Cited by 359 · see citing works

Identification and Characterization of Galectin-9, a Novel β-Galactoside-binding Mammalian Lectin

Wada, J., & Kanwar, Y. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.6078 · Cited by 337 · see citing works

Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 Pathway

Kashio, Y., Nakamura, K., Abedin, M. J., Seki, M., Nishi, N., Yoshida, N., Nakamura, T., & Hirashima, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3631 · Cited by 304 · see citing works

Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes

Matsumoto, R., Matsumoto, H., Matsumoto, H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16976 · Cited by 304 · see citing works

Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

Wada, J., Ota, K., Kumar, A., Wallner, E. I., & Kanwar, Y. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119429 · Cited by 280 · see citing works

Ah, sweet mystery of death! Galectins and control of cell fate

Hernandez, J. D., & Baum, L. G. (2002) · Glycobiology · doi:10.1093/glycob/cwf081 · Cited by 217 · see citing works

T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis

Khademi, M., Illés, Z., Gielen, A. W., Marta, M., Takazawa, N., Baecher‐Allan, C., Brundin, L., Hannerz, J., Martin, C., Harris, R. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7169 · Cited by 215 · see citing works

Human Galectin-2: Novel Inducer of T Cell Apoptosis with Distinct Profile of Caspase Activation

Sturm, A., Lensch, M., André, S., Kaltner, H., Wiedenmann, B. J., Rosewicz, S., Dignass, A. U., & Gabius, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3825 · Cited by 213 · see citing works

Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain.

Oda, Y., Herrmann, J., Gitt, M. A., Turck, C. W., Burlingame, A. L., Barondes, S. H., & Leffler, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53409-8 · Cited by 182 · see citing works

Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells.

Imaizumi, T., Kumagai, M., Sasaki, N., Kurotaki, H., Mori, F., Seki, M., Nishi, N., Fujimoto, K., Tanji, K., Shibata, T., et al. (2002) · PubMed · Cited by 170 · see citing works

Interferon-γ stimulates the expression of galectin-9 in cultured human endothelial cells

Imaizumi, T., Kumagai, M., Sasaki, N., Kurotaki, H., Mori, F., Seki, M., Nishi, N., Fujimoto, K., Tanji, K., Shibata, T., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.3.486 · Cited by 149 · see citing works

Requirement of Divalent Galactoside-binding Activity of Ecalectin/Galectin-9 for Eosinophil Chemoattraction

Matsushita, N., Nishi, N., Seki, M., Matsumoto, R., Kuwabara, I., Liu, F., Hata, Y., Nakamura, T., & Hirashima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8355 · Cited by 144 · see citing works

Selective Eosinophil Adhesion to Fibroblast Via IFN-γ-Induced Galectin-9

Asakura, H., Kashio, Y., Nakamura, K., Seki, M., Dai, S., Shirato, Y., Abedin, M. J., Yoshida, N., Nishi, N., Imaizumi, T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5912 · Cited by 140 · see citing works

Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance

Pender, M. P., McCombe, P., Yoong, G., & Nguyen, K. B. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90001-7 · Cited by 109 · see citing works

The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis

Chae, S., Park, Y., Shim, S. C., Yoon, K., & Chung, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.008 · Cited by 77 · see citing works

Interleukin-1β stimulates galectin-9 expression in human astrocytes

Yoshida, H., Imaizumi, T., Kumagai, M., et al. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00030 · Cited by 61 · see citing works

The blockade of immune checkpoints in cancer immunotherapy

Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229 · see citing works

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154 · see citing works

Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation

Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096 · see citing works

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Koyama, S., Akbay, E. A., Li, Y. Y., Herter-Sprie, G. S., Buczkowski, K. A., Richards, W. G., Gandhi, L., Redig, A. J., Rodig, S. J., Asahina, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10501 · Cited by 1,580 · see citing works

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01489-2 · Cited by 1,445 · see citing works

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients

Fourcade, J., Sun, Z., Benallaoua, M., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Kuchroo, V., & Zarour, H. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100637 · Cited by 1,307 · see citing works

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1091-2 · Cited by 1,145 · see citing works

TIM3 comes of age as an inhibitory receptor

Wolf, Y., Anderson, A. C., & Kuchroo, V. K. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0224-6 · Cited by 959 · see citing works

HMGB1 in health and disease

Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956 · see citing works

Tim‐3 and its role in regulating anti‐tumor immunity

Das, M., Zhu, C., & Kuchroo, V. K. (2017) · Immunological Reviews · doi:10.1111/imr.12520 · Cited by 856 · see citing works

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838 · see citing works

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752 · see citing works

CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

Huang, Y.-H., Zhu, C., Kondo, Y., Anderson, A. C., Gandhi, A., Russell, A., Dougan, S. K., Petersen, B.-S., Melum, E., Pertel, T., et al. (2015) · Nature · doi:10.1038/nature13848 · Cited by 717 · see citing works

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

Zhou, Q., Munger, M. E., Veenstra, R. G., Weigel, B. J., Hirashima, M., Munn, D. H., Murphy, W. J., Azuma, M., Anderson, A. C., Kuchroo, V. K., et al. (2011) · Blood · doi:10.1182/blood-2010-10-310425 · Cited by 675 · see citing works

Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., et al. (2007) · Nature Immunology · doi:10.1038/ni1482 · Cited by 653 · see citing works

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma

Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Liu, J., Shi, L., Liu, C., Wang, G., et al. (2012) · Hepatology · doi:10.1002/hep.25777 · Cited by 496 · see citing works

Reversing T-cell Dysfunction and Exhaustion in Cancer

Zarour, H. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1849 · Cited by 462 · see citing works

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion

Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394 · see citing works

TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer

de Mingo Pulido, Á., Gardner, A., Hiebler, S., Soliman, H., Rugo, H. S., Krummel, M. F., Coussens, L. M., & Ruffell, B. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.019 · Cited by 388 · see citing works

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Ravi, R., Noonan, K. A., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., Makarev, E., V. Artemov, A., Wysocki, P. T., Mehra, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02696-6 · Cited by 325 · see citing works

Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways

Lee, J., Su, E. W., Zhu, C., Hainline, S., Phuah, J., Moroco, J. A., Smithgall, T. E., Kuchroo, V. K., & Kane, L. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05297-11 · Cited by 285 · see citing works

IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells

Chinnadurai, R., Copland, I. B., Patel, S. R., & Galipeau, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301828 · Cited by 266 · see citing works

VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy

Lines, J. L., Sempere, L. F., Broughton, T., Wang, L., & Noelle, R. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0072 · Cited by 236 · see citing works

Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease

Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., Rose, N. R., & Fairweather, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6710 · Cited by 212 · see citing works

A highly conserved tyrosine of Tim‐3 is phosphorylated upon stimulation by its ligand galectin‐9

van de Weyer, P. S., Muehlfeit, M., Klose, C., Bonventre, J. V., Walz, G., & Kuehn, E. W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.079 · Cited by 198 · see citing works

Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations

Kerr, E. C., Raveney, B. J. E., Copland, D. A., Dick, A. D., & Nicholson, L. B. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.08.006 · Cited by 162 · see citing works

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion

Huang, X., Bai, X., Cao, Y., Wu, J., Huang, M., Tang, D., Tao, S., Zhu, T., Liu, Y., Yang, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090397 · Cited by 156 · see citing works

The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia

Koh, H. S., Chang, C. Y., Jeon, S.-B., Yoon, H. J., Ahn, Y.-H., Kim, H.-S., Kim, I.-H., Jeon, S. H., Johnson, R. S., & Park, E. J. (2015) · Nature Communications · doi:10.1038/ncomms7340 · Cited by 141 · see citing works

T Cell Ig and Mucin Domain–Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases

Clayton, K. L., Haaland, M. S., Douglas-Vail, M. B., Mujib, S., Chew, G. M., Ndhlovu, L. C., & Ostrowski, M. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302663 · Cited by 134 · see citing works

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs

Gupta, S., Thornley, T. B., Gao, W., Larocca, R., Turka, L. A., Kuchroo, V. K., & Strom, T. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45138 · Cited by 139 · see citing works

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma

Yu, C., Liu, X., Yang, J., Zhang, M., Jin, H., Ma, X., & Shi, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00990 · Cited by 126 · see citing works

Targeting the immune microenvironment in acute myeloid leukemia: a focus on T cell immunity

Lamble, A. J., & Lind, E. F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00213 · Cited by 119 · see citing works

Glycobiology of cell death: when glycans and lectins govern cell fate

Lichtenstein, R. G., & Rabinovich, G. A. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.50 · Cited by 107 · see citing works

The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer

Alemohammad, H., Najafzadeh, B., Asadzadeh, Z., Baghbanzadeh, A., Ghorbaninezhad, F., Najafzadeh, A., Safarpour, H., Bernardini, R., Brunetti, O., Sonnessa, M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112516 · Cited by 92 · see citing works

Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components

de Kivit, S., Kraneveld, A. D., Garssen, J., & Willemsen, L. E. M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.086 · Cited by 94 · see citing works

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases

Cai, X., Zhan, H., Ye, Y., Yang, J., Zhang, M., Li, J., & Zhuang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.785153 · Cited by 66 · see citing works

T Cell, Ig Domain, Mucin Domain-2 Gene-Deficient Mice Reveal a Novel Mechanism for the Regulation of Th2 Immune Responses and Airway Inflammation

Rennert, P. D., Ichimura, T., Sizing, I. D., Bailly, V., Li, Z., Rennard, R., McCoon, P., Pablo, L., Miklasz, S., Tarilonte, L., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4311 · Cited by 67 · see citing works

Phosphatidylserine binding directly regulates TIM-3 function

Smith, C. M., Li, A., Krishnamurthy, N., & Lemmon, M. A. (2021) · Biochemical Journal · doi:10.1042/bcj20210425 · Cited by 61 · see citing works

Role and therapeutic implications of protein glycosylation in neuroinflammation

Rebelo, A. L., Chevalier, M. T., Russo, L., & Pandit, A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.01.004 · Cited by 50 · see citing works

Immune checkpoint inhibitors associated cardiovascular immune-related adverse events

Jo, W., Won, T., Daoud, A., & Čiháková, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1340373 · Cited by 55 · see citing works

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors

Roy, D., Gilmour, C., Patnaik, S., & Wang, L. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264327 · Cited by 53 · see citing works

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis

Quinn, J., Salman, A., Paluch, C., Jackson-Wood, M., McClements, M. E., Luo, J., Davis, S. J., Cornall, R. J., MacLaren, R. E., Dendrou, C. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68401-y · Cited by 32 · see citing works

Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease

Kremers, B. M. M., Posma, J. N., Heitmeier, S., Glunz, J., ten Cate, H., Pallares Robles, A., Daemen, J. H. C., ten Cate-Hoek, A. J., Mees, B. M. E., & Spronk, H. M. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-23260-3 · Cited by 17 · see citing works

Intracellular functions of galectins

Liu, F. T. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00313-6 · Cited by 676 · see citing works

Immunological tolerance and autoimmunity

Zelada-Valdés, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822564-6.00009-4 · Cited by 4 · see citing works

Homeostatic mechanisms in the control of autoimmunity

Heath, V. L., Mason, D., Ramirez, F., et al. (1997) · Seminars in Immunology · doi:10.1006/smim.1997.0095 · Cited by 21 · see citing works

The multiple pathways to autoimmunity

Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590 · see citing works

LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity

Proekt, I., Miller, C. N., Jeanne, M., Fasano, K. J., Moon, J. J., Lowell, C. A., Gould, D. B., Anderson, M. S., & DeFranco, A. L. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84440 · Cited by 26 · see citing works